# Clinical trials recruiting in Missouri: 1,985 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 1,985 trials recruiting or not yet recruiting with a site in Missouri, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Missouri: 1,985 rows for $99.25, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 34 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/missouri

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 1,985
- Recruiting or not yet: 1,985
- Read on: November 19, 2026

## Trials

The 25 newest of 1,985, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07940036 | Skin Cancer Detection in Primary Care With and Without DermaSensor | DermaSensor, Inc. | Not applicable | Not yet recruiting | Skin Cancer, Basal Cell Cancer, Squamous Cell Carcinoma, Melanoma (Skin Cancer), Melanoma In Situ, Melanoma Detection... | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940036) |
| November 16, 2026 | NCT07937982 | Protocol CAUSE-05 RHINO | National Institute of Allergy and Infectious Diseases (NIAID) | Observational | Not yet recruiting | Asthma, Respiratory Health | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937982) |
| November 12, 2026 | NCT07931599 | A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 1,060 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931599) |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 10, 2026 | NCT07929506 | Prophylactic CPAP for Late Preterm Infants Born by C-Section to Reduce NICU Admission | Indiana University | Not applicable | Not yet recruiting | Late Preterm Infant | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929506) |
| November 9, 2026 | NCT07924241 | Medically Tailored Meals to Improve Cancer Outcomes | Washington University School of Medicine | Not applicable | Recruiting | Cancer, Healthy Eating | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924241) |
| November 5, 2026 | NCT07919405 | A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Hypertension, Obesity | 1,408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919405) |
| November 5, 2026 | NCT07918859 | A Study of Imlunestrant (LY3484356) in Healthy Female Participants | Eli Lilly and Company | Phase 1 | Not yet recruiting | Healthy | 343 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07918859) |
| November 4, 2026 | NCT07916883 | PET-MR Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Multisite) | Washington University School of Medicine | Observational | Recruiting | Carotid Atherosclerosis, Carotid Artery Stenosis Asymptomatic, Asymptomatic Carotid Artery Stenosis | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916883) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| November 3, 2026 | NCT07914673 | Age-Associated Differences in Germinal Center Responses to Influenza and Rabies Vaccination in Humans | Washington University School of Medicine | Phase 4 | Recruiting | Healthy Adult Participants, Age 65 and Older, Age 18 to 40, Immunology | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07914673) |
| November 3, 2026 | NCT07914309 | Dexamethasone De-Escalation in Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast Cancer | Washington University School of Medicine | Phase 2 | Not yet recruiting | Triple Negative Breast Cancer, Triple Negative Breast Cancer (TNBC), Breast Cancer | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07914309) |
| November 2, 2026 | NCT07910266 | Impact of Egg-Based and Cell-Based Vaccine Platforms on Immune Responses to Repeated Influenza Vaccination | University of Missouri-Columbia | Phase 4 | Recruiting | Immunology | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07910266) |
| November 2, 2026 | NCT07908199 | Oura Ring OA15 Validation | Ouraring Inc. | Observational | Recruiting | Healthy Adult, Sleep Apnea | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07908199) |
| October 30, 2026 | NCT07907991 | The AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary Disease | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Chronic Obstructive Pulmonary Disease | 1,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907991) |
| October 28, 2026 | NCT07901803 | Aspirin and PAClitaxel in Head & Neck Squamous Cell Carcinoma | Washington University School of Medicine | Phase 2 | Not yet recruiting | Head and Neck (HNSCC), Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Head and Neck... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07901803) |
| October 28, 2026 | NCT07900893 | Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 3 | Washington University School of Medicine | Not applicable | Recruiting | Schizophrenia / Schizoaffective Disorder, SCHIZOPHRENIA 1 (Disorder), Healthy Adult | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900893) |
| October 28, 2026 | NCT07900633 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900633) |
| October 26, 2026 | NCT07895420 | Comparing Intravitreal Injection Pain Scores Using Iheezo (Chloroprocaine Hcl Ophthalmic Gel 3%) Versus Subconjunctival Lidocaine (2%): A... | Retina Research Institute, LLC | Phase 4 | Recruiting | No Condition | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895420) |
| October 22, 2026 | NCT07890610 | Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest | Children's Hospital of Philadelphia | Observational | Recruiting | Cardiac Arrest (CA) | 1,620 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890610) |
| October 22, 2026 | NCT07890376 | A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes | Eli Lilly and Company | Phase 2 | Not yet recruiting | Obesity, Overweight | 460 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890376) |
| October 21, 2026 | NCT07886905 | Pulsed Stereotactic Ablative Radiotherapy (PULSAR) With Systematic Therapy for Thyroid Cancer | Washington University School of Medicine | Phase 2 | Not yet recruiting | Anaplastic Thyroid Carcinoma, Thyroid Cancer, Thyroid Carcinoma | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07886905) |
| October 20, 2026 | NCT07884175 | A Study of Updated mRNA Seasonal Influenza Vaccines | ModernaTX, Inc. | Phase 4 | Recruiting | Seasonal Influenza | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07884175) |
| October 20, 2026 | NCT07881887 | A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 Diabetes | Eli Lilly and Company | Phase 1 | Recruiting | Obesity, Overweight, Diabetes Mellitus, Type 2 | 617 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881887) |
| October 19, 2026 | NCT07881458 | A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes | Eli Lilly and Company | Phase 3 | Recruiting | Obesity, Overweight, Diabetes Mellitus, Type 2 | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881458) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Washington University School of Medicine | St Louis | 472 |
| Washington University | St Louis | 132 |
| Mercy Hospital Saint Louis | St Louis | 86 |
| Saint Francis Medical Center | Cape Girardeau | 83 |
| Siteman Cancer Center-South County | St Louis | 83 |
| Siteman Cancer Center at West County Hospital | Creve Coeur | 82 |
| Siteman Cancer Center at Saint Peters Hospital | City of Saint Peters | 80 |
| Washington University in St. Louis | St Louis | 79 |
| Siteman Cancer Center at Christian Hospital | St Louis | 78 |
| Mercy Hospital South | St Louis | 76 |
| Missouri Baptist Medical Center | St Louis | 76 |
| Mercy Hospital Springfield | Springfield | 69 |
| Sainte Genevieve County Memorial Hospital | Sainte Genevieve | 66 |
| Missouri Baptist Sullivan Hospital | Sullivan | 65 |
| Parkland Health Center - Farmington | Farmington | 63 |
| CoxHealth South Hospital | Springfield | 54 |
| University of Kansas Cancer Center - North | Kansas City | 53 |
| Heartland Regional Medical Center | Saint Joseph | 52 |
| University of Kansas Cancer Center - Lee's Summit | Lee's Summit | 52 |
| University of Missouri | Columbia | 50 |
| Freeman Health System | Joplin | 45 |
| Mercy Hospital Joplin | Joplin | 44 |
| Mercy Clinic-Rolla-Cancer and Hematology | Rolla | 44 |
| Lake Regional Hospital | Osage Beach | 42 |
| Mercy Oncology and Hematology - Clayton-Clarkson | Ballwin | 42 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 16 |
| Phase 1 | 159 |
| Phase 1/2 | 132 |
| Phase 2 | 396 |
| Phase 2/3 | 60 |
| Phase 3 | 535 |
| Phase 4 | 57 |
| Not applicable | 347 |
| Observational | 283 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 84 |
| Breast Neoplasms | 84 |
| Obesity | 68 |
| Neoplasms | 65 |
| Neoplasm Metastasis | 63 |
| Colorectal Neoplasms | 62 |
| Prostatic Neoplasms | 53 |
| Lung Neoplasms | 45 |
| Heart Failure | 41 |
| Overweight | 40 |
| Pancreatic Neoplasms | 36 |
| Ovarian Neoplasms | 36 |
| Squamous Cell Carcinoma of Head and Neck | 34 |
| Endometrial Neoplasms | 34 |
| Cardiovascular Diseases | 30 |
| Multiple Myeloma | 30 |
| Alzheimer Disease | 29 |
| Urinary Bladder Neoplasms | 27 |
| Diabetes Mellitus, Type 2 | 26 |
| Melanoma | 26 |
| Stomach Neoplasms | 26 |
| Leukemia, Myeloid, Acute | 25 |
| Triple Negative Breast Neoplasms | 24 |
| Carcinoma, Renal Cell | 23 |
| Crohn Disease | 23 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Washington University School of Medicine | 232 |
| National Cancer Institute (NCI) | 75 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 66 |
| University of Missouri-Columbia | 56 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 44 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 34 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 27 |
| SWOG Cancer Research Network | 26 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 25 |
| Children's Oncology Group | 25 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 23 |
| Alliance for Clinical Trials in Oncology | 22 |
| NRG Oncology | 21 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 21 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 20 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 20 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 19 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 19 |
| Children's Mercy Hospital Kansas City | 17 |
| VA Office of Research and Development | 16 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 16 |
| St. Louis University | 16 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 14 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 14 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 13 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Missouri

- [Security companies in Missouri, United States](https://specstream.ai/data/businesses/security-companies/missouri-united-states)
- [Personal injury law firms in Missouri, United States](https://specstream.ai/data/businesses/personal-injury-law-firms/missouri-united-states)
- [Lodges in Missouri, United States](https://specstream.ai/data/businesses/lodges/missouri-united-states)
- [Gutter contractors in Missouri, United States](https://specstream.ai/data/businesses/gutter-contractors/missouri-united-states)
- [Document shredding companies in Missouri, United States](https://specstream.ai/data/businesses/document-shredding-companies/missouri-united-states)
- [Business law firms in Missouri, United States](https://specstream.ai/data/businesses/business-law-firms/missouri-united-states)
